PRESS RELEASE published on 10/22/2025 at 18:30, 1 year ago 2024-2025 annual results in line with targets // 2025-26 outlook: Revenue of over EUR 510 million and recurring operating margin around 9%, Leverage of less than 3x and decrease in financial expenses Groupe Bastide announces 2024-2025 annual results. Revenue up 6.3% to €491.2 million. Recurring operating margin at 9.0%. Net profit of €1.6 million. Outlook positive for 2025-2026 with expected revenue of at least €510 million Revenue Outlook Operating Margin Groupe Bastide 2024-2025
BRIEF published on 10/02/2025 at 18:05, 1 year ago BASTIDE Le Confort Médical: Status of shares and voting rights as of September 30, 2025 Voting Rights Actions AMF 2025 Bastide
BRIEF published on 09/24/2025 at 18:05, 1 year 1 month ago Baywater Healthcare sale to Sapio Group completes Acquisition Strategy Bastide Group Assignment Baywater Healthcare Sapio Group
PRESS RELEASE published on 09/24/2025 at 18:00, 1 year 1 month ago Groupe Bastide completes the sale of Baywater Healthcare to Sapio Group Groupe Bastide completes the sale of Baywater Healthcare to Sapio Group, doubling in size since 2018 and reducing debt significantly. Next publication: 2024-2025 annual results on October 22, 2025 Revenue Growth Sale Annual Results Groupe Bastide Baywater Healthcare
BRIEF published on 09/04/2025 at 18:05, 1 year 1 month ago Bastide's Financial Results for 2024-2025 Unveiled Profitability Organic Growth Turnover Respiratory Nutrition-Perfusion
PRESS RELEASE published on 09/04/2025 at 18:00, 1 year 1 month ago 2024-2025 revenue target met // 2024-2025 revenue from continuing operations: EUR 491 million, up 8% ( EUR 561 million, excluding impact of disposals) Groupe Bastide reports annual revenue growth of 8.0% for 2024-2025, reaching €491.2 million, driven by strong performance in the fourth quarter. The company confirms its profitability target and maintains a revenue target of over €500 million for 2025-2026 Annual Revenue Groupe Bastide 2024-2025 Profitability Target 2025-2026
BRIEF published on 09/03/2025 at 18:20, 1 year 1 month ago BASTIDE: Information on shares and voting rights as of August 31, 2025 Share Capital Voting Rights Actions Bastide Medical
BRIEF published on 08/01/2025 at 18:10, 1 year 2 months ago Shares and voting rights within Bastide Le Confort Médical Common Shares Exercisable Voting Rights Preference Shares Capital Structure Theoretical Voting Rights
BRIEF published on 07/03/2025 at 18:20, 1 year 3 months ago Update of Bastide Le Confort Médical shares and voting rights as of June 30, 2025 Voting Rights Actions AMF 2025 Bastide
BRIEF published on 06/30/2025 at 07:35, 1 year 3 months ago Bastide Group sells Baywater Healthcare to Sapio Group Debt Reduction Bastide Assignment Sccio Sapio Baywater Healthcare
Published on 10/24/2026 at 00:04, 1 day 22 hours ago Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters
Published on 10/23/2026 at 23:30, 1 day 23 hours ago Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita
Published on 10/23/2026 at 21:55, 2 days 1 hour ago Apex Closes Offering and Completes NASDAQ Listing
Published on 10/23/2026 at 16:00, 2 days 6 hours ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/24/2026 at 23:44, 24 hours 14 minutes ago EQS-Adhoc: HomeToGo SE: Unauthorized data exfiltration at subsidiary SECRA Bookings GmbH
Published on 10/24/2026 at 14:15, 1 day 8 hours ago Winners of the 2026 INPD Awards Announced, C-Beauty Takes Home Multiple Prestigious Honors
Published on 10/24/2026 at 06:30, 1 day 16 hours ago AI and EV Boom Draws $690 Million in Advanced Materials Investment Plans to Thailand
Published on 10/23/2026 at 18:55, 2 days 4 hours ago Qatar's Years of Culture Initiative Announces Partner Countries Through 2030
Published on 10/23/2026 at 18:00, 2 days 4 hours ago BIOSYNEX SA: CHEMBIO DIAGNOSTIC SYSTEMS AWARDED $5.7 MILLION TO ADVANCE DPP® BIOTHREAT PANEL
Published on 10/23/2026 at 20:33, 2 days 2 hours ago Disclosure of transactions in own shares from October 19 to October 23, 2026
Published on 10/23/2026 at 17:45, 2 days 5 hours ago Imerys-10-2026-information-share-capital-and-voting-rights-as-of-30-September-2026
Published on 10/22/2026 at 18:00, 3 days 4 hours ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 3 days 4 hours ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics